Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer - PubMed (original) (raw)
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
Ole H Sjo et al. Dis Colon Rectum. 2012 Mar.
Abstract
Background: The prognostic impact of the number of lymph nodes and ratio in colon cancer is still debated.
Objectives: The aim of this study was to evaluate lymph node harvest in patients with colon cancer over time, and to test the hypotheses that investigation of more lymph nodes, and low lymph node ratio in stage III patients, has positive prognostic impact.
Design: This is a prospective, observational study.
Settings: This study was conducted in a single institution treating all patients with colon cancer in a defined catchment area.
Patients: All patients admitted in the period 1993 to 2009 (n = 1481) were included.
Main outcome measures: The primary outcomes measured were the number of examined regional lymph nodes according to treatment period, 5-year overall survival and time to recurrence, and univariate (Kaplan-Meier) and multivariate (Cox regression) analyses of prognostic factors.
Results: Nine hundred fifty (65%) patients underwent curative resection. Median number of examined lymph nodes increased from 7 to 15 (p < 0.001), and the proportion of patients with stage III disease increased from 25% to 33% (p = 0.02) during the study period. In patients with stage I to III disease, time to recurrence (proportion of patients without recurrence or death of colon cancer) improved from 65% to 82% during the period (p < 0.001). An association between lymph node count (<8 compared with ≥ 12) and overall survival was found for patients with stage II disease (57% vs 71%, p = 0.004). Hazard ratio for death within 5 years was 0.7 (p = 0.043) when 8 to 11 nodes were examined and 0.6 (p = 0.001) when ≥ 12 nodes were examined (<8 reference). In patients with stage III disease, increasing lymph node ratio was associated with reduced overall survival and time to recurrence in uni- and multivariate analyses.
Limitations: This study was limited by the small number of patients in each stage.
Conclusions: The number of examined lymph nodes increased in the study period. A stage migration was observed, and time to recurrence improved in patients with stage I to III disease. In patients with stage III disease, lymph node ratio was a stronger prognostic factor than the total number of lymph nodes examined.
Similar articles
- The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study.
Lykke J, Roikjaer O, Jess P; Danish Colorectal Cancer Group. Lykke J, et al. Colorectal Dis. 2013 May;15(5):559-65. doi: 10.1111/codi.12059. Colorectal Dis. 2013. PMID: 23061638 - Effect of Lymph Node Retrieval and Ratio on the Long-Term Survival and Recurrence of Colon Cancer.
Rao A, Dadras M, Razzak MA, Ahmad K, Vijayasekar C. Rao A, et al. J Coll Physicians Surg Pak. 2016 Jun;26(6):467-70. J Coll Physicians Surg Pak. 2016. PMID: 27353981 - Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
Gleisner AL, Mogal H, Dodson R, Efron J, Gearhart S, Wick E, Lidor A, Herman JM, Pawlik TM. Gleisner AL, et al. J Am Coll Surg. 2013 Dec;217(6):1090-100. doi: 10.1016/j.jamcollsurg.2013.07.404. Epub 2013 Sep 14. J Am Coll Surg. 2013. PMID: 24045143 - Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Chang GJ, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):433-41. doi: 10.1093/jnci/djk092. J Natl Cancer Inst. 2007. PMID: 17374833 Review. - Lymph Nodes-On-Chip: Promising Immune Platforms for Pharmacological and Toxicological Applications.
Shanti A, Hallfors N, Petroianu GA, Planelles L, Stefanini C. Shanti A, et al. Front Pharmacol. 2021 Aug 16;12:711307. doi: 10.3389/fphar.2021.711307. eCollection 2021. Front Pharmacol. 2021. PMID: 34483920 Free PMC article. Review.
Cited by
- Impact of Metastatic Lymph Node Ratio on Survival and Prognosis in Rectal Carcinoma: A Retrospective Cohort Study.
Kartal B, Tutan MB. Kartal B, et al. Cureus. 2024 Sep 5;16(9):e68734. doi: 10.7759/cureus.68734. eCollection 2024 Sep. Cureus. 2024. PMID: 39371737 Free PMC article. - Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancer.
Dai X, Dai Z, Fu J, Liang Z, Du P, Wu T. Dai X, et al. World J Surg Oncol. 2024 Jul 19;22(1):186. doi: 10.1186/s12957-024-03469-4. World J Surg Oncol. 2024. PMID: 39030562 Free PMC article. - Robotic versus laparoscopic left colectomy with complete mesocolic excision for left-sided colon cancer: a multicentre study with propensity score matching analysis.
Zheng H, Wang Q, Fu T, Wei Z, Ye J, Huang B, Li C, Liu B, Zhang A, Li F, Gao F, Tong W. Zheng H, et al. Tech Coloproctol. 2023 Jul;27(7):569-578. doi: 10.1007/s10151-023-02788-0. Epub 2023 Apr 4. Tech Coloproctol. 2023. PMID: 37014449 - Robotic versus laparoscopic left colectomy with complete mesocolic excision for left-sided colon cancer: a multicentre study with propensity score matching analysis.
Zheng H, Wang Q, Fu T, Wei Z, Ye J, Huang B, Li C, Liu B, Zhang A, Li F, Gao F, Tong W. Zheng H, et al. Tech Coloproctol. 2023 Jul;27(7):559-568. doi: 10.1007/s10151-023-02781-7. Epub 2023 Mar 25. Tech Coloproctol. 2023. PMID: 36964884 - Computer-Assisted Differentiation between Colon-Mesocolon and Retroperitoneum Using Hyperspectral Imaging (HSI) Technology.
Okamoto N, Rodríguez-Luna MR, Bencteux V, Al-Taher M, Cinelli L, Felli E, Urade T, Nkusi R, Mutter D, Marescaux J, Hostettler A, Collins T, Diana M. Okamoto N, et al. Diagnostics (Basel). 2022 Sep 15;12(9):2225. doi: 10.3390/diagnostics12092225. Diagnostics (Basel). 2022. PMID: 36140626 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources